Low Risk of Chronic Graft Versus Host Disease and Relapse Associated with T-Cell Depleted Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0303

Graft versus host disease (GVHD) is most effectively prevented by ex vivo T cell depletion (TCD) of the allograft but its role in the treatment of patients undergoing allogeneic hematopoietic cell transplantation (HCT) for acute myeloid leukemia (AML) in complete remission (CR) remains unclear. We t...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Devine, Steven M., Carter, Shelly, Soiffer, Robert J, Pasquini, Marcelo C., Hari, Parameswaran N, Stein, Anthony, Lazarus, Hillard M., Linker, Charles, Stadtmauer, Edward A., Alyea, Edwin P., Keever-Taylor, Carolyn A., O'Reilly, Richard J
פורמט: Artigo
שפה:Inglês
יצא לאור: 2011
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3150599/
https://ncbi.nlm.nih.gov/pubmed/21320619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.02.002
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים